Related Experiment Videos
Lung cancer cure, care, and cost: let the data be your guide
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Deciphering radiological stable disease to immune checkpoint inhibitors.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
COVID-19 in patients with lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026